• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他唑巴坦与所有主要结构类型的β-内酰胺酶的动力学相互作用。

Kinetic interactions of tazobactam with beta-lactamases from all major structural classes.

作者信息

Bush K, Macalintal C, Rasmussen B A, Lee V J, Yang Y

机构信息

Medical Research Division, American Cyanamid, Pearl River, New York 10965.

出版信息

Antimicrob Agents Chemother. 1993 Apr;37(4):851-8. doi: 10.1128/AAC.37.4.851.

DOI:10.1128/AAC.37.4.851
PMID:8388201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC187782/
Abstract

Tazobactam was shown to be a potent inhibitor of group 1, 2a, 2b, and 2b' beta-lactamases. Extended kinetic studies with class A and C serine beta-lactamases showed that the PC1, TEM-2, and P99 enzymes all were reversibly inhibited prior to inactivation of the enzymes. The CcrA metallo-beta-lactamase was less well inhibited, with a 50% inhibitory concentration at least 3 orders of magnitude less favorable than those for most serine beta-lactamases. The numbers of hydrolytic turnovers of tazobactam before inactivation were 2 for PC1, 125 for TEM-2, 50 for P99, and 4,000 for the CcrA enzyme. In spectral studies, transient intermediates were formed after reaction of tazobactam with the PC1, TEM-2, and CcrA beta-lactamases, corresponding to enzyme-associated intermediates responsible for hydrolysis of tazobactam. Chromophores absorbing at 270 nm (CcrA) and 288 nm (TEM-2 and PC1) were observed for these reaction intermediates. The P99 cephalosporinase formed a stable complex with a UV maximum at 295 nm. Incubation of tazobactam with all of the enzymes resulted in accumulation of a tazobactam reaction product with a short-wavelength absorbance. This product has characteristics similar to those of the major eucaryotic metabolite of tazobactam. Possible reaction mechanisms are presented to explain the findings. In conclusion, both serine-based and metallo-beta-lactamases were irreversibly inactivated by tazobactam following an initial transient inhibition phase.

摘要

他唑巴坦被证明是1、2a、2b和2b'组β-内酰胺酶的有效抑制剂。对A类和C类丝氨酸β-内酰胺酶进行的扩展动力学研究表明,PC1、TEM-2和P99酶在失活之前均被可逆抑制。CcrA金属β-内酰胺酶的抑制效果较差,其50%抑制浓度比大多数丝氨酸β-内酰胺酶的50%抑制浓度至少低3个数量级。PC1、TEM-2、P99和CcrA酶失活前他唑巴坦的水解周转数分别为2、125、50和4000。在光谱研究中,他唑巴坦与PC1、TEM-2和CcrAβ-内酰胺酶反应后形成了瞬态中间体,这与负责他唑巴坦水解的酶相关中间体相对应。观察到这些反应中间体在270nm(CcrA)和288nm(TEM-2和PC1)处有发色团吸收。P99头孢菌素酶形成了一种在295nm处有最大紫外吸收的稳定复合物。他唑巴坦与所有这些酶一起孵育导致了一种具有短波长吸收的他唑巴坦反应产物的积累。该产物具有与他唑巴坦主要真核代谢产物相似的特征。文中提出了可能的反应机制来解释这些发现。总之,在初始的瞬态抑制阶段之后,丝氨酸类和金属β-内酰胺酶均被他唑巴坦不可逆地失活。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cab/187782/19d97eb61672/aac00026-0264-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cab/187782/19d97eb61672/aac00026-0264-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cab/187782/19d97eb61672/aac00026-0264-a.jpg

相似文献

1
Kinetic interactions of tazobactam with beta-lactamases from all major structural classes.他唑巴坦与所有主要结构类型的β-内酰胺酶的动力学相互作用。
Antimicrob Agents Chemother. 1993 Apr;37(4):851-8. doi: 10.1128/AAC.37.4.851.
2
Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases.棒酸、舒巴坦和他唑巴坦对临床重要β-内酰胺酶的比较活性。
Antimicrob Agents Chemother. 1994 Apr;38(4):767-72. doi: 10.1128/AAC.38.4.767.
3
Effect of clavulanic acid, sulbactam and tazobactam on three different beta-lactamases from Bacteroides uniformis, Clostridium butyricum and Fusobacterium nucleatum.
J Antimicrob Chemother. 1992 Jul;30(1):17-25. doi: 10.1093/jac/30.1.17.
4
Mechanism of inhibition of the class A beta -lactamases PC1 and TEM-1 by tazobactam. Observation of reaction products by electrospray ionization mass spectrometry.
J Biol Chem. 2000 Sep 1;275(35):26674-82. doi: 10.1074/jbc.M002369200.
5
Effect of pH on activities of novel beta-lactamases and beta-lactamase inhibitors against these beta-lactamases.pH对新型β-内酰胺酶及β-内酰胺酶抑制剂针对这些β-内酰胺酶活性的影响。
Antimicrob Agents Chemother. 1995 Aug;39(8):1856-8. doi: 10.1128/AAC.39.8.1856.
6
Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors.筛选由临床来源质粒编码的、对β-内酰胺酶抑制剂耐药性增强的TEM-1β-内酰胺酶变体。
J Antimicrob Chemother. 1993 May;31(5):655-64. doi: 10.1093/jac/31.5.655.
7
Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin.他唑巴坦对β-内酰胺酶的抑制作用以及他唑巴坦与哌拉西林联合的体外抗菌活性。
J Antimicrob Chemother. 1990 Apr;25(4):567-74. doi: 10.1093/jac/25.4.567.
8
Effect of beta-lactamase inhibitors on beta-lactamases from anaerobic bacteria.
Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1100-4. doi: 10.1007/BF01967805.
9
Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I beta-lactamases.他唑巴坦和克拉维酸与诱导型和组成型表达的I类β-内酰胺酶的相互作用。
J Antimicrob Chemother. 1990 Feb;25(2):199-208. doi: 10.1093/jac/25.2.199.
10
Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum beta-lactamase, TEM-60.斯氏普罗威登斯菌对头孢他啶和氨曲南的耐药性:一种天然TEM衍生的超广谱β-内酰胺酶TEM-60的特性
Antimicrob Agents Chemother. 1998 Jun;42(6):1459-62. doi: 10.1128/AAC.42.6.1459.

引用本文的文献

1
A high-resolution screen identifies a preexisting beta-lactam that specifically treats Lyme disease in mice.高分辨率筛选鉴定出一种先前存在的β-内酰胺,它能特异性治疗小鼠的莱姆病。
Sci Transl Med. 2025 Apr 23;17(795):eadr9091. doi: 10.1126/scitranslmed.adr9091.
2
Risk factors and drug resistance of adult community-onset urinary tract infections caused by producing extended-spectrum β-lactamase in the Chongqing region, China: a retrospective case-control study.中国重庆地区产超广谱β-内酰胺酶的成人社区获得性尿路感染的危险因素和耐药性:一项回顾性病例对照研究。
BMJ Open. 2024 Oct 29;14(10):e090665. doi: 10.1136/bmjopen-2024-090665.
3

本文引用的文献

1
Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase.甲磺酸酯作为乙酰胆碱酯酶的不可逆抑制剂
J Biol Chem. 1962 Oct;237:3245-9.
2
ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type.大肠杆菌K-12的AmpC头孢菌素酶与青霉素酶型β-内酰胺酶有着不同的进化起源。
Proc Natl Acad Sci U S A. 1981 Aug;78(8):4897-901. doi: 10.1073/pnas.78.8.4897.
3
Purification of beta-lactamases by affinity chromatography on phenylboronic acid-agarose.
Characterization of acquired β-lactamases in and quantification of their contributions to resistance.
研究获得性β-内酰胺酶的特性及其对耐药性的贡献。
Microbiol Spectr. 2024 Oct 3;12(10):e0069424. doi: 10.1128/spectrum.00694-24. Epub 2024 Sep 9.
4
Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility Testing.肠杆菌科细菌哌拉西林/他唑巴坦敏感性试验的解释标准:美国抗菌药物敏感性试验委员会的建议
Clin Infect Dis. 2024 Dec 17;79(6):1354-1362. doi: 10.1093/cid/ciae328.
5
Identification and characterization of a novel β-lactamase gene, , from .从……中鉴定并表征一种新型β-内酰胺酶基因……
Front Microbiol. 2023 Sep 21;14:1252427. doi: 10.3389/fmicb.2023.1252427. eCollection 2023.
6
Heterogeneity in M. tuberculosis β-lactamase inhibition by Sulbactam.利奈唑胺对结核分枝杆菌β-内酰胺酶的抑制作用存在异质性。
Nat Commun. 2023 Sep 7;14(1):5507. doi: 10.1038/s41467-023-41246-1.
7
Retrospective analysis of drug resistance characteristics and infection related risk factors of multidrug-resistant organisms (MDROs) isolated from the orthopedics department of a tertiary hospital.回顾性分析某三甲医院骨科分离的多药耐药菌(MDROs)耐药特点及感染相关危险因素。
Sci Rep. 2023 Feb 7;13(1):2199. doi: 10.1038/s41598-023-28270-3.
8
Heterogeneity in the M. tuberculosis β-Lactamase Inhibition by Sulbactam.舒巴坦对结核分枝杆菌β-内酰胺酶抑制作用的异质性
Res Sq. 2023 Jan 10:rs.3.rs-2334665. doi: 10.21203/rs.3.rs-2334665/v1.
9
Characterization and identification of a novel chromosomal class C β-lactamase, LAQ-1, and comparative genomic analysis of a multidrug resistance plasmid in P13.新型染色体C类β-内酰胺酶LAQ-1的表征与鉴定以及P13中多药耐药质粒的比较基因组分析
Front Microbiol. 2022 Nov 23;13:990736. doi: 10.3389/fmicb.2022.990736. eCollection 2022.
10
Probability of Target Attainment Analyses to Inform Ceftolozane/Tazobactam Dosing Regimens for Patients With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia and End-Stage Renal Disease Receiving Intermittent Hemodialysis.目标达成概率分析以指导接受间歇性血液透析的医院获得性或呼吸机相关性细菌性肺炎和终末期肾病患者的头孢他洛/他唑巴坦给药方案。
J Clin Pharmacol. 2023 Feb;63(2):166-171. doi: 10.1002/jcph.2149. Epub 2022 Oct 2.
通过苯基硼酸 - 琼脂糖亲和层析法纯化β - 内酰胺酶。
Biochem J. 1984 Jul 15;221(2):505-12. doi: 10.1042/bj2210505.
4
Penicillanic acid sulfone: interaction with RTEM beta-lactamase from Escherichia coli at different pH values.
Biochemistry. 1981 Jun 23;20(13):3688-95. doi: 10.1021/bi00516a004.
5
Penicillanic acid sulfone: an unexpected isotope effect in the interaction of 6 alpha- and 6 beta-monodeuterio and of 6,6-dideuterio derivatives with RTEM beta-lactamase from Escherichia coli.
Biochemistry. 1981 Jun 23;20(13):3680-7. doi: 10.1021/bi00516a003.
6
The structure of beta-lactamases.β-内酰胺酶的结构
Philos Trans R Soc Lond B Biol Sci. 1980 May 16;289(1036):321-31. doi: 10.1098/rstb.1980.0049.
7
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin.β-内酰胺酶抑制剂YTR 830、克拉维酸钠和舒巴坦与阿莫西林或氨苄西林联合使用的比较活性。
Antimicrob Agents Chemother. 1984 Oct;26(4):580-2. doi: 10.1128/AAC.26.4.580.
8
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.在噬菌体T4头部组装过程中结构蛋白的切割
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.
9
A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.一种用于检测聚丙烯酰胺凝胶中氚标记蛋白质和核酸的胶片检测方法。
Eur J Biochem. 1974 Jul 1;46(1):83-8. doi: 10.1111/j.1432-1033.1974.tb03599.x.
10
Cryoenzymology of Bacillus cereus beta-lactamase II.蜡样芽孢杆菌β-内酰胺酶II的低温酶学
Biochemistry. 1985 Nov 19;24(24):6876-87. doi: 10.1021/bi00345a021.